1178PDA phase I trial of GEN-009, a neoantigen vaccine...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1178PDA phase I trial of GEN-009, a neoantigen vaccine using ATLAS™, an autologous immune assay, to identify immunogenic and inhibitory tumour mutations

Twardowski, P, Johnson, M L, Stein, M, Vaishampayan, U, Gillison, M L, McNeil, L, Dowal, L, DeOliveira, D, Jain, M, Price, J, Hernandez, R, DeCillis, A, Singh, N, Davis, T, Flechtner, J, Cohen, R B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.004
Date:
October, 2019
File:
PDF, 90 KB
2019
Conversion to is in progress
Conversion to is failed